Copyright Reports & Markets. All rights reserved.

Global Ocular Drug Delivery System Market Research Report 2021

Request for Sample of this report
Buy now

1 Ocular Drug Delivery System Market Overview

  • 1.1 Product Overview and Scope of Ocular Drug Delivery System
  • 1.2 Ocular Drug Delivery System Segment by Type
    • 1.2.1 Global Ocular Drug Delivery System Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Implantable Ocular Drug Delivery Systems
    • 1.2.3 Particulate Drug Delivery Systems
  • 1.3 Ocular Drug Delivery System Segment by Application
    • 1.3.1 Ocular Drug Delivery System Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Ambulatory Surgical Centers
  • 1.4 Global Ocular Drug Delivery System Market Size Estimates and Forecasts
    • 1.4.1 Global Ocular Drug Delivery System Revenue 2016-2027
    • 1.4.2 Global Ocular Drug Delivery System Sales 2016-2027
    • 1.4.3 Ocular Drug Delivery System Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ocular Drug Delivery System Market Competition by Manufacturers

  • 2.1 Global Ocular Drug Delivery System Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Ocular Drug Delivery System Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Ocular Drug Delivery System Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Ocular Drug Delivery System Manufacturing Sites, Area Served, Product Type
  • 2.5 Ocular Drug Delivery System Market Competitive Situation and Trends
    • 2.5.1 Ocular Drug Delivery System Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Ocular Drug Delivery System Players Market Share by Revenue
    • 2.5.3 Global Ocular Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ocular Drug Delivery System Retrospective Market Scenario by Region

  • 3.1 Global Ocular Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Ocular Drug Delivery System Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Ocular Drug Delivery System Market Facts & Figures by Country
    • 3.3.1 North America Ocular Drug Delivery System Sales by Country
    • 3.3.2 North America Ocular Drug Delivery System Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Ocular Drug Delivery System Market Facts & Figures by Country
    • 3.4.1 Europe Ocular Drug Delivery System Sales by Country
    • 3.4.2 Europe Ocular Drug Delivery System Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Ocular Drug Delivery System Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Ocular Drug Delivery System Sales by Region
    • 3.5.2 Asia Pacific Ocular Drug Delivery System Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Ocular Drug Delivery System Market Facts & Figures by Country
    • 3.6.1 Latin America Ocular Drug Delivery System Sales by Country
    • 3.6.2 Latin America Ocular Drug Delivery System Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Ocular Drug Delivery System Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Ocular Drug Delivery System Sales by Country
    • 3.7.2 Middle East and Africa Ocular Drug Delivery System Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Ocular Drug Delivery System Historic Market Analysis by Type

  • 4.1 Global Ocular Drug Delivery System Sales Market Share by Type (2016-2021)
  • 4.2 Global Ocular Drug Delivery System Revenue Market Share by Type (2016-2021)
  • 4.3 Global Ocular Drug Delivery System Price by Type (2016-2021)

5 Global Ocular Drug Delivery System Historic Market Analysis by Application

  • 5.1 Global Ocular Drug Delivery System Sales Market Share by Application (2016-2021)
  • 5.2 Global Ocular Drug Delivery System Revenue Market Share by Application (2016-2021)
  • 5.3 Global Ocular Drug Delivery System Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Ocular Therapeutix
    • 6.1.1 Ocular Therapeutix Corporation Information
    • 6.1.2 Ocular Therapeutix Description and Business Overview
    • 6.1.3 Ocular Therapeutix Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Ocular Therapeutix Product Portfolio
    • 6.1.5 Ocular Therapeutix Recent Developments/Updates
  • 6.2 Alimera Sciences
    • 6.2.1 Alimera Sciences Corporation Information
    • 6.2.2 Alimera Sciences Description and Business Overview
    • 6.2.3 Alimera Sciences Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Alimera Sciences Product Portfolio
    • 6.2.5 Alimera Sciences Recent Developments/Updates
  • 6.3 Allergan
    • 6.3.1 Allergan Corporation Information
    • 6.3.2 Allergan Description and Business Overview
    • 6.3.3 Allergan Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Allergan Product Portfolio
    • 6.3.5 Allergan Recent Developments/Updates
  • 6.4 Graybug Vision
    • 6.4.1 Graybug Vision Corporation Information
    • 6.4.2 Graybug Vision Description and Business Overview
    • 6.4.3 Graybug Vision Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Graybug Vision Product Portfolio
    • 6.4.5 Graybug Vision Recent Developments/Updates
  • 6.5 Bausch Health
    • 6.5.1 Bausch Health Corporation Information
    • 6.5.2 Bausch Health Description and Business Overview
    • 6.5.3 Bausch Health Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Bausch Health Product Portfolio
    • 6.5.5 Bausch Health Recent Developments/Updates
  • 6.6 EyePoint Pharmaceuticals
    • 6.6.1 EyePoint Pharmaceuticals Corporation Information
    • 6.6.2 EyePoint Pharmaceuticals Description and Business Overview
    • 6.6.3 EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 EyePoint Pharmaceuticals Product Portfolio
    • 6.6.5 EyePoint Pharmaceuticals Recent Developments/Updates
  • 6.7 Santen Pharmaceutical
    • 6.6.1 Santen Pharmaceutical Corporation Information
    • 6.6.2 Santen Pharmaceutical Description and Business Overview
    • 6.6.3 Santen Pharmaceutical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Santen Pharmaceutical Product Portfolio
    • 6.7.5 Santen Pharmaceutical Recent Developments/Updates
  • 6.8 Taiwan Liposome
    • 6.8.1 Taiwan Liposome Corporation Information
    • 6.8.2 Taiwan Liposome Description and Business Overview
    • 6.8.3 Taiwan Liposome Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Taiwan Liposome Product Portfolio
    • 6.8.5 Taiwan Liposome Recent Developments/Updates
  • 6.9 Envisia Therapeutics
    • 6.9.1 Envisia Therapeutics Corporation Information
    • 6.9.2 Envisia Therapeutics Description and Business Overview
    • 6.9.3 Envisia Therapeutics Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Envisia Therapeutics Product Portfolio
    • 6.9.5 Envisia Therapeutics Recent Developments/Updates
  • 6.10 Clearside Biomedical
    • 6.10.1 Clearside Biomedical Corporation Information
    • 6.10.2 Clearside Biomedical Description and Business Overview
    • 6.10.3 Clearside Biomedical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Clearside Biomedical Product Portfolio
    • 6.10.5 Clearside Biomedical Recent Developments/Updates

7 Ocular Drug Delivery System Manufacturing Cost Analysis

  • 7.1 Ocular Drug Delivery System Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Ocular Drug Delivery System
  • 7.4 Ocular Drug Delivery System Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Ocular Drug Delivery System Distributors List
  • 8.3 Ocular Drug Delivery System Customers

9 Ocular Drug Delivery System Market Dynamics

  • 9.1 Ocular Drug Delivery System Industry Trends
  • 9.2 Ocular Drug Delivery System Growth Drivers
  • 9.3 Ocular Drug Delivery System Market Challenges
  • 9.4 Ocular Drug Delivery System Market Restraints

10 Global Market Forecast

  • 10.1 Ocular Drug Delivery System Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Ocular Drug Delivery System by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Ocular Drug Delivery System by Type (2022-2027)
  • 10.2 Ocular Drug Delivery System Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Ocular Drug Delivery System by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Ocular Drug Delivery System by Application (2022-2027)
  • 10.3 Ocular Drug Delivery System Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Ocular Drug Delivery System by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Ocular Drug Delivery System by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Implantable Ocular Drug Delivery Systems
    Particulate Drug Delivery Systems

    Segment by Application
    Hospitals
    Clinics
    Ambulatory Surgical Centers

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Ocular Therapeutix
    Alimera Sciences
    Allergan
    Graybug Vision
    Bausch Health
    EyePoint Pharmaceuticals
    Santen Pharmaceutical
    Taiwan Liposome
    Envisia Therapeutics
    Clearside Biomedical

    Buy now